Identifying the specific factors which stimulate mucus for IL-4 in mucus production (6-9). In addition, the Th2 of IL-13 is shown, requiring its complete blockade for a significytokine IL-9 appeared to play a key role in the induction cant reduction in mucus production. We show that mucus inof airway epithelial mucus (10-13).
common signaling mechanism. Our goal was also to gain insight into how universal are these pathways in chronic In chronic inflammatory diseases of the airways like asthma, inflammatory airway diseases. We now define a single excess mucus production causes significant morbidity, as it IL-13-mediated pathway by which CD4 T cells stimulate obstructs airways and contributes to symptoms, including mucus and we map in vivo how IL-13 leads to this highly coughing and wheezing (1, 2) . In autopsy specimens from potent effect on the airway epithelium. patients who died in status asthmaticus, obstructing plugs of mucus and cellular debris have been identified in the
Materials and Methods
small airways. Activated CD4 Th2 cells infiltrate the airways Mice in patients with asthma, and in animal models of asthma Th2 cells have been shown to stimulate mucus hyperproduc- Ϫ/Ϫ BALB/c mice were graciously provided by Dr. Andrew tion (3, 4) .
McKenzie. DO11.10 mice, which are transgenic (Tg) for the T cell receptor (TCR) recognizing ovalbumin (OVA) peptide 323-339 (pOVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] ) were kindly provided to us on BALB/c background by Ken Murphy (Washington University, St. Louis, MO) and were (Received in original form February 11, 2002 Becton Dickinson, San Jose, CA) analysis was performed on Th2 cell preparations to determine the purity of transferred cell populations. Cells were stained with anti-CD4 (Quantum Red-L3T4; Sigma) and in DO11.10 Tg populations, the biotinylated anticlono-
Generation of Th1 and Th2 Cells
typic antibody, KJ1-26, and fluorescein isothiocyanate-avidin D To generate Th2 cells from IL-13 ϩ/ϩ or IL-13 Ϫ/Ϫ DO11.10 mice, (Vector Laboratories, Burlingame, CA). KJ1-26 is specific for the CD4 T cells were isolated by negative selection as previously Tg TCR in the DO11.10 mice. Transferred cells were uniformly described (4) using monoclonal antibodies to CD8 and Class II more than 96% CD4 positive. After a period of inhalational expo-MHC I-A and anti-Ig-coated magnetic beads (Collaborative Resure, BAL and lung cells were analyzed by FACS using these search, Inc., Bedford, MA). In some cases naive CD4 T cells were antibodies. Isolation of lung lymphocytes was performed after further isolated using anti-CD62L (Mel14; BD Pharmingen, San BAL and perfusion of blood from lungs. Lung tissue was passed Diego, CA) and MACS (Milltenyi, Auburn, CA). To generate through a wire mesh, digested with collagenase Type IV (150 U/ml; Th2 cells from non-Tg mice, C57BL/6 mice were injected intraperiWorthington Biochemical, Freehold, NJ) and DNase 10 units/ml toneally with 100 g of OVA (Sigma Chemical Co., St. Louis, (Sigma) for 1 h at 37ЊC and passed again through a wire mesh to MO) in 4.5 mg of alum. Seven days after immunization, spleens dissociate cells. and local draining lymph nodes were harvested and CD4 T cells isolated. Syngeneic T-depleted splenocytes were used as antigenpresenting cells (APC) and prepared by negative selection using
Lung Histology
anti-CD4, -CD8, and anti-Thy-1 antibodies and treatment with Lungs were prepared for histology by perfusing the animal via the rabbit complement. APCs were mitomycin-C treated. To generate right ventricle with 20 ml of PBS. Lungs were then inflated with Th2 cells, CD4 T cells were stimulated with pOVA 323-339 (5 g/ml), 1.0 ml of fixative instilled through a tracheostomy tube. Samples IL-4 (1-10 ng/ml; Peprotech, Rocky Hill, NJ) and anti-IFN-␥ at for paraffin sectioning were formalin fixed, sectioned in the coronal inhibitory concentration. To generate Th1 cells, CD4 T cells were plane at 5 m, and periodic acid Schiff (PAS) and Alcian blue stains stimulated with pOVA 323-339 (5 g/ml), IL-12 (7.5 ng/ml; Genetics were performed. Histologic mucus index (HMI) was performed on Institute, Cambridge, MA) and anti-IL-4 at inhibitory concentra-PAS-stained sections that included both central and peripheral tion. All cultures were set up in flasks containing a 1:2 ratio of airways on which marker dots in a grid with 2-mm spacing were CD4 T cells and APCs at a concentration of 2.5 ϫ 10 5 CD4 T placed over the entire lung section. The slide was examined at ϫ100 cells/ml for TCR Tg and 1 ϫ 10 6 for non-Tg cells, and were mainfinal magnification on an Olympus BH-2 microscope (Olympus, tained for 4 d.
Tokyo, Japan) with a rectangular 10-mm square reticule grid (American Optical Corp., Buffalo, NY) inserted in one eyepiece. Each marker dot was placed in the lower left corner of the field, and all intersections of airway epithelium with the reticle grid were
Transfer of Cells and Aerosol Administration of OVA
counted in that field, distinguishing mucus-containing or normal Cultured Th2-like cells were harvested after 4 d, washed with epithelium. Approximately 25% of the total lung section was phosphate-buffered saline (PBS), and 2.5-6 ϫ 10 6 cells were inscored. The ratio of total number of mucus positive intersections jected intravenously into syngeneic recipient mice. One day after and the total of all intersections, which we call the HMI, is equivatransfer of cells, mice were challenged with inhaled 1% OVA in lent to the linear percent of epithelium positive for mucus. This PBS as previously described (4), for 20 min/d for a total of 7 d index was calculated for each mouse lung and then the mean of over a period of 9 d (four consecutive days exposed, 2 d rested, the HMI was calculated for each experimental group. HMI results were previously validated on Alcian blue-and mucicarminethree consecutive days exposed). Control mice received inhaled stained sections. OVA only. For experiments using IL-13 inhibitor, 400 g sIL-13R␣2-Fc or control Hu Ig (generously provided by Dr. Debra Donaldson, Genetics Institute) was administered intranasally to mice each day before OVA exposure. Mice were killed 24 h after Reverse Transcription-Polymerase Chain Reaction the final OVA exposure.
Total RNA was isolated from the left lung of each mouse after being homogenized in TrizolReagent (Gibco BRL, Gaithersburg, MD) and extracted according to the manufacturer's instructions. The RNA pellet was suspended in nuclease-free H 2 O. To synthe-
Cytokine Assays
size cDNA, random primers were annealed to 4 g of total lung At the time of transfer, an aliquot of Th2-like cells was retained RNA by incubation at 65ЊC for 5 min. Reverse transcription (RT) for restimulation. 2.5 ϫ 10 5 CD4 T cells/ml, 2.5 ϫ 10 5 /ml freshly was performed by adding dNTP, an RNAse inhibitor (RNAse isolated APCs and pOVA (5 g/ml) were cultured, and superna-OUT; Gibco BRL), 0.1 M DTT, 50 U SuperScriptII (Gibco BRL), tants were collected at 24 h. IFN-␥, IL-4, IL-5 (Endogen, Camand buffer, and incubating at 42ЊC for 50 min and finally at 70ЊC bridge, MA), and IL-13 (BD Pharmingen) levels from cell supernafor 15 min to terminate the reaction. The cDNAs synthesized were tants were determined by ELISA. The lower limit of sensitivity used in polymerase chain reaction (PCR). PCR was performed for each of the ELISAs was 0.5 ng/ml for IFN-␥, 0.010 ng/ml for using primer sets corresponding to murine muc5ac (14) and HPRT. IL-4, 0.010 ng/ml for IL-5, and 0.025 ng/ml for IL-13. IFN-␥, IL-4,
The sequences of the primers were: muc5ac: 5Ј-GGA CCA AGT IL-13 (R&D Systems, Minneapolis, MN), and IL-9 levels from GGT TTG ACA CTG AC-3Ј (forward) and 5Ј-CCT CAT AGT bronchoalveolar lavage (BAL) fluid were determined by enzyme-TGA GGC ACA TCC CAG-3Ј (reverse); HPRT: 5Ј-GTT GGA linked immunosorbent assay (ELISA). The lower limit of sensitiv-TAC AGG CCA GAC TTT GTT G-3Ј (forward) and 5Ј-GAG ity for each of the ELISAs was 8 pg/ml for IFN-␥, 4 pg/ml for GGT AGG CTG GCC TAT AGG CT-3Ј (reverse). The reactions were assembled with 10 M dNTP, 1ϫ reaction buffer (Promega, IL-4, 8 pg/ml for IL-13, and 0.140 ng/ml for IL-9.
not detectable ( Table 1 ). The levels of IL-4 and IL-13 were higher in IL-4R␣ Ϫ/Ϫ mice, consistent with the increase in CD4, KJ1.26-expressing cells in the BAL. We further confirmed that the lack of mucus staining in IL-4R␣ Ϫ/Ϫ mice was not a result of IFN-␥, an inhibitor of mucus (16) , because mucus was not induced when Th2 cells were transferred into IL-4R␣ Ϫ/Ϫ ϫ IFN-␥R Ϫ/Ϫ mice (data not shown).
Thus, it appears that the absence of mucus induction in IL-4R␣Ϫ/Ϫ mice is not due to a block in Th2 cell recruitment, proliferation, activity, or a shift in the cytokines produced in vivo.
Because IL-4R␣ is the common receptor chain for both IL-4 and IL-13, these data indicated a role for IL-13 in the stimulation of mucus. However, it was not clear if both IL-13 and IL-4 or only IL-13 regulated Th2-induced mucus (18) . In four different experiments, bePartially Blocks, Th2-Induced Mucus Production tween 2.5 and 6 ϫ 10 6 IL-13 ϩ/ϩ or IL-13 Ϫ/Ϫ Th2 cells were Using an adoptive transfer system in which in vitro-generated transferred into IL-13 ϩ/ϩ or IL-13 Ϫ/Ϫ recipient mice, and mice were exposed to inhaled OVA for 7 d. IL-13 ϩ/ϩ mice TCR Tg DO11.10 CD4 Th1 or Th2 cells were transferred that received IL-13 ϩ/ϩ or IL-13 Ϫ/Ϫ Th2 cells and IL-13 Ϫ/Ϫ into recipient mice, we previously showed that Th2, but not mice that received IL-13 ϩ/ϩ Th2 cells and inhaled OVA Th1, cells stimulate airway epithelial mucus (4). IL-4 Ϫ/Ϫ had airway inflammation and a marked increase in airway Th2 cells were able to stimulate mucus production, but mucus ( Figure 2B ). However, in the complete absence of mucus was not induced when IL-4 Ϫ/Ϫ Th2 cells were trans-IL-13, when IL-13 Ϫ/Ϫ mice received IL-13 Ϫ/Ϫ Th2 cells and ferred into IL-4R␣ Ϫ/Ϫ mice (5). We now show that mucus inhaled antigen, there was no mucus staining in airway epithestaining is also blocked when 2. producing cells were present in ample quantity in the respiraFurthermore, both IL-4 and IL-13 were measured in the tory tract. These data show that IL-13 is required for Th2-induced mucus, even when high levels of IL-4 are present. BAL fluid from both groups of mice, whereas IFN-␥ was Together with the data in Figure 1 , these experiments show IL-13 Stimulates Increased Muc5ac Gene Expression that only complete blockade of IL-13 will eliminate airway Increased mucin gene expression in airway epithelial cells epithelial mucus staining.
has been shown to correlate with histologic mucus staining Despite a lack of mucus staining, lung histopathology of (19) . In mice and humans, the mucin glycoprotein genes IL-13 Ϫ/Ϫ mice that received IL-13 Ϫ/Ϫ Th2 cells showed air-MUC2 and MUC5ac can be upregulated in airway epithelial way epithelial cell hypertrophy ( Figure 3 ). This finding cells in response to various stimuli (20) . RT-PCR on RNA shows that in the absence of IL-13, Th2 cells can activate samples from whole lung showed that muc5ac gene expresepithelial hypertrophic changes typically associated with sion was increased in wild-type (IL-4R␣ ϩ/ϩ or IL-13 ϩ/ϩ ) mucus hyperproduction, but the inflammatory response is mice that received transfer of wild-type (IL-13 ϩ/ϩ ) Th2 cells not sufficient to induce mucus metaplasia.
and inhaled OVA ( Figure 4 ). These were mice that exhibited increased mucus staining by PAS and Alcian blue staining. Muc2 expression was not detectable (data not shown). Muc 5ac expression was markedly reduced in lungs from IL-13 Ϫ/Ϫ mice that received IL-13 Ϫ/Ϫ Th2 cells and IL-4R␣ Ϫ/Ϫ mice that received Th2 cells compared with wildtype recipient mice (IL-13 ϩ/ϩ and IL-4R␣ ϩ/ϩ ) that received Th2 cells. There was a low level of muc5ac gene expression in IL-4R␣ ϩ/ϩ or IL-4R␣ Ϫ/Ϫ mice that received no transfer of cells and inhaled OVA, and these mice had no appreciable histologic mucus staining. In these experiments, mucus staining correlates with a striking increase in muc5ac mRNA. Thus, Th2 cells producing IL-4 alone, in the absence of IL-13, do not stimulate a robust increase in muc5ac mRNA, supporting our findings that IL-4 cannot stimulate mucus production in vivo.
IL-9-Induced Mucus Production Is Dependent on IL-4R␣
IL-9 is a Th2 cytokine that is believed to play an important role in the pathogenesis of asthma (21) . Airway epithelial mucus production was a striking feature of CC10 IL-9 Tg mice that overexpressed IL-9 in a lung-specific fashion (10). intranasally to CC10 IL-9 Tg mice for 8 d. Mucus staining IL-4R␣ Ϫ/Ϫ → IL-4R␣ Ϫ/Ϫ ). Two months after bone marrow reconstitution, DO11.10 Th2 cells were transferred into was blocked in mice that received sIL-13R␣2-Fc, whereas mice that received the control Ig exhibited extensive PAS each of the chimeras and mice were exposed to inhaled OVA. As expected, mucus was induced in IL-4R␣ ϩ/ϩ → ILstaining of the airways ( Figure 5B ). These studies show that IL-9-induced airway mucus is mediated by IL-13. , or IL-13 Ϫ/Ϫ recipient mice received transfer of wild-type DO11.10 Th2 cells (Th2 or IL-13 ϩ/ϩ Th2) or IL-13 Ϫ/Ϫ Th2 cells. Control mice did not receive cells. All mice were exposed to inhaled OVA. Total RNA was extracted from one lung of each animal in an experimental group and RT-PCR was performed using primers for muc5ac and the housekeeping gene, HPRT. PCR products were run on an agarose gel stained with ethidium bromide. Each lane represents RNA from an individual mouse; lanes  1-3, 4-6, 7-8, or 9-10 show RNA from mice in the same experimental group. or p50 Ϫ/Ϫ mice, which do not display DNA binding activity for NF-B (24) . After exposure to inhaled OVA, both p50 ϩ/ϩ and p50 Ϫ/Ϫ recipient mice exhibited comparable muduction when IL-4R␣ is absent on structural cells. IL-13 cus staining of the airway epithelium, HMI 54% (Ϯ 13) in may bind to its receptor on nonhematopoietic cells within p50 ϩ/ϩ mice versus 77% (Ϯ 6) in p50 Ϫ/Ϫ mice (n ϭ 4 mice the lung, possibly the bronchial epithelial cells, and stimuper group, P ϭ NS). These studies show that the induction late mucus production.
of mucus by Th2 cells does not require NF-B. . Statistical significance was determined by unpaired Student's t test.
Th1-Induced Mucus, in the Absence of IFN-␥, Is IL-13-Dependent
was administered (Figure 7) . CD4, KJ1.26-expressing cells were present in the BAL in both groups of mice (Th1 ϩ had marked airway inflammation with lymphocytes and eosinophils, both with the potential to produce IL-13. IL-4 HuIg, 5 ϫ 10 4 Ϯ 1.2; Th1ϩ sIL-13R␣2-Fc, 9 ϫ 10 4 Ϯ 1.1). Wild-type mice that received HuIg and Th1 cells did not instilled in the airways of lymphocyte-deficient mice also led to increased mucus staining and eosinophilia (8) . IL-13 exhibit mucus staining. Th1 cells, therefore, are capable of mucus induction, not by an alternate pathway mediated by is produced predominantly by Th2 cells, but other inflammatory cells like mast cells, basophils, and NK cells have neutrophils, but via the same IL-13-mediated pathway of Th2 cells. In addition, the low level of IL-13 produced by been shown to produce IL-13 (33, 34) , and our recent studies in RAG Ϫ/Ϫ mice indicate that sufficient IL-13 is produced Th1 cells is sufficient to stimulate mucus.
by nonlymphoid cells to stimulate mucus production (L. Cohn, unpublished data). High levels of recombinant IL-4
Discussion
were also shown to increase mucin gene expression in culThese studies define a unique function for IL-13 in the tured human airway epithelial cell lines (9) . Although this induction of airway epithelial mucus in vivo. Neither IL-4, system appears to be free of contaminating IL-13, it is unnor IL-9 produced by Th2 cells, nor any factor produced known whether the bronchial epithelium can produce very by Th1 cells upon activation, can stimulate mucus in the low levels of IL-13. An alternate explanation is that high absence of IL-13. IL-13 is highly potent in its ability to and sustained levels of IL-4 stimulate mucus. If this is the stimulate mucus, as shown by Th1 cells, which produce 100-case, then the threshold for mucus induction was not fold less IL-13 than Th2 cells, yet still can stimulate mucus achieved in our transfer system despite the magnitude of staining in 60-70% of the bronchial epithelial cells. There-IL-4 produced by and the increased number of activated, fore, inhibiting IL-13 must be absolute to eliminate mucus antigen-specific Th2 cells in the respiratory tract of IL-13 Ϫ/Ϫ production, because partial blockade only leads to a modest recipient mice. Under physiologic conditions, it is unlikely reduction in mucus staining of airway epithelial cells.
that IL-4 will manifest an effect on mucus in the absence Multiple different inflammatory mediators have been of IL-13. associated with airway epithelial mucus production in asthma.
IL-4 and IL-13 have many overlapping functions due Cytokines, leukotrienes, histamine, platelet-activating facto signaling through the common receptor chain, IL-4R␣, tor, eosinophil cationic protein, and reactive oxygen species and activation of the transcription factor, Stat6. Both IL-4 are elevated in the airways of individuals with asthma and and IL-13 stimulate Th2 cell generation, IgE production, and have been shown to stimulate mucus secretion (25) (26) (27) (28) (29) . In most aspects of host protective immunity to parasites (35) . murine models of antigen-induced airway inflammation, the IL-13 has a unique in vivo function in gastrointestinal expulinduction of mucus requires the presence of activated CD4 sion of the parasitic nematode, Nippostrongylus braziliensis Th2 cells (4) . Because CD4 T cells activate cascades of (36, 37) . Our current studies support the conclusions of inflammation, dissecting out the critical factors that influothers that IL-13 has another unique function in the inducence mucus production and secretion has been complex. In tion of airway epithelial mucus production (32, 38, 39) . experiments employing blockade of leukotrienes or PAF, These IL-13 effects on the epithelium could be due to differthere was a reduction in airway mucus, but these data sugences in either signal transduction of IL-4 and IL-13 through gested that Th2 lymphocytes in the respiratory tract were their receptors (40) , the magnitude and kinetics of IL-13 also decreased (30, 31). Thus, these investigations did not and IL-4 production, or cellular expression of the receptors identify whether a specific mediator could enhance mucus (35) . Although these appear to be direct effects of IL-13 indirectly by increasing Th2 inflammation or directly by stimon the epithelium, there is also enhanced accumulation of ulating mucus production. In earlier studies we showed that Th2 cells in the respiratory tract in the absence of IL-13; Th2 cells could stimulate mucus in the absence of IL-5, therefore, these studies cannot rule out an undefined, indieosinophils, and mast cells. Furthermore, mucus was inrect effect of IL-13 on mucus. duced by Th2 cells in the absence of IL-4, but not when Th2 cytokines, aside from IL-4 and IL-13, have been both IL-4 and IL-13 signaling were blocked in IL-4R␣ Ϫ/Ϫ shown to stimulate mucus. Most recently, IL-9 was proposed mice (5). IL-4R␣ appeared to mediate Th2-induced mucus to be a key cytokine determining asthma susceptibility, production. Wills-Karp and Grunig showed that an IL- 13 given its chromosomal localization in humans and its associinhibitor caused a modest reduction in mucus production ation with bronchial hyperresponsiveness and mucus hyperin an antigen-driven model of asthma (8, 17 ). Yet these secretion in mice (10, 21) . IL-9 is produced by Th2 cells studies did not clarify whether IL-4 could stimulate mucus and mast cells and has been shown to promote T cell growth in the absence of IL-13 or if mucus resulted from insufficient blockade of IL-13. Furthermore, in IL-13 Ϫ/Ϫ mice, mucus and IgE production, and to stimulate growth and differentiation of mast cells (41) . Tg mice that constitutively overexwas inhibited in one antigen-driven model of lung inflammation (32), but only partially reduced using another antipress IL-9 in the respiratory tract had marked mucus staining in the airway epithelium and airway inflammation with genic stimulus (13) . Thus, it was unclear if factors other than IL-13 could stimulate mucus in a Th2-driven model increased numbers of Th2 cells, eosinophils, and mast cells (10) . IL-9 applied in vitro to cultured airway epithelial cells of lung inflammation.
Some in vivo models suggested that IL-4 could stimulate led to mucus production and muc5ac gene expression (11, 12) . Although these studies support a direct role for IL-9 mucus. In many cases, though, IL-13-producing cells were not completely absent from the experimental systems. In in mucus induction, other studies suggest that IL-9 activates an inflammatory cascade that leads to mucus induction. In mice that overexpressed IL-4 in the respiratory tract, mucus production was markedly increased (6, 7). Yet these mice IL-9-deficient mice, mucus production was reduced in the lung after a primary infection with Schistosoma, but it was of two polypeptide subunits, p50 and Rel A (p65). In p50 Ϫ/Ϫ mice immunized and challenged with OVA, inflammation not impaired in a secondary response (13) . These experiments, together with other recent studies (42) , show clearly and mucus production were reduced, suggesting an important role for NF-B in Th2-induced inflammatory responses that IL-9 stimulates mucus production by increasing production of IL-13, because mucus staining was negligible in IL-9 in vivo (24) . Recent studies showed that inhibition of NF-B prevented GATA-3 expression and Th2 cytokine expresTg mice that were deficient in IL-4R␣ or that received an IL-13 inhibitor, despite continued local production of IL-9.
sion, including IL-4, IL-5, and IL-13, in developing Th2 cells (50). We now show that committed Th2 cells that IL-9 may enhance IL-13 levels through proinflammatory effects on mast cells, which are activated early in pulmonary produce cytokines can stimulate mucus production in the absence of NF-B. Therefore, the original defect in mucus immune responses and can produce IL-13 (33) .
IL-10 overexpressed in the respiratory tract of mice was production we observed in immunized p50 Ϫ/Ϫ mice resulted from defective Th2 cell generation and not from an effect recently shown to cause increased airway epithelial mucus production and airway inflammation. Mucus was inhibited of NF-B on mucus. These data suggest that NF-B p50 is not essential for muc5ac gene expression. Although in vivo when these animals were backcrossed to IL-4R␣ Ϫ/Ϫ or IL-13 Ϫ/Ϫ mice (43) . Together with the data presented herein, studies characterizing Muc2 regulation have not yet been performed, it appears that the mucin genes, Muc2 and Muit appears that Th2 cytokines can promote mucus production by enhancing inflammation, Th2 cell generation, and c5AC, are regulated differently by different inflammatory stimuli. In keeping with these findings, when LPS was inultimately IL-13 production, because Th2 cells stimulate mucus exclusively by an IL-13-mediated pathway.
stilled intranasally into IL-4R␣ Ϫ/Ϫ and IL-13 Ϫ/Ϫ mice, mucus was induced (L. Cohn, unpublished observation), further We previously showed that Th1 cells could stimulate mucus production if IFN-␥ effects were blocked (16) . Th1 supporting the theory that different host responses have evolved to promote mucus production. cells stimulate a vigorous neutrophilic airway inflammatory response and we initially theorized that Th1 cells might be Mucus production is one of many mechanisms by which the airway epithelium responds to pathogens and injury. stimulating mucus by a neutrophilic pathway. Neutrophil elastase, epithelial growth factor, and TNF-␣ have been
The epithelial layer also secretes other substances important in host defense, functions as a physical barrier to entry of shown to stimulate airway epithelial mucus (44, 45) . Yet, our studies showed that despite the presence of neutrophilia, an foreign matter, and interacts with cells in close apposition through local signaling mechanisms and at distant sites IL-13 inhibitor blocked mucus production after transfer of Th1 cells into IFN-␥R Ϫ/Ϫ mice. These findings argue against through release of chemical mediators. Th2 inflammation in the airway stimulates epithelial hypertrophy and mucus a neutrophil-stimulated pathway of mucus induction, such as the model proposed by Takeyama and coworkers in metaplasia. In the absence of IL-13, Th2 cells still activate the epithelium to undergo hypertrophy, yet none of the which IL-13-induced mucus is mediated by neutrophils through the elaboration of TNF-␣, epithelial growth factor, cytokines produced by these cells can provide the appropriate stimulus to activate mucus production. These are the and oxidants causing EGFR activation (44, 46, 47) . Additionally, our studies using bone marrow chimeras indicate first studies to show a dissociation of epithelial hypertrophy and mucus metaplasia. Although it is well known that hyperthat IL-13 cannot stimulate mucus solely through effects on inflammatory cells, like neutrophils. When IL-4R␣ was trophy is an adaptive response of different cell types to increased metabolic demands (51), the functions affected by present on bone marrow derived inflammatory cells, but not on the structural cells in the lung, mucus was not induced airway epithelial hypertrophy, aside from mucus induction, have not been previously studied. Future studies using this by Th2 cells producing IL-13. IL-13-induced mucus may involve complex interactions between IL-4R␣ and other model system will allow us to study the epithelial responses in asthma that are distinct from mucus metaplasia, and may receptors, like EGFR or IL-9R, yet these interactions appear to depend on IL-4R␣ for the induction of mucus. Our provide new insights into epithelial effects in the airway remodeling response. data suggests that IL-9 stimulates IL-13 production, placing IL-4R␣ signaling downstream of IL-9 in the inflammatory Many Th2 cytokines have been shown to stimulate mucus. We now established a single, common pathway by cascade that leads to mucus production. The detailed interactions of IL-13/IL-4R␣ and EGFR or other inflammatory which mucus is induced in a CD4 Th inflammatory response. Cytokines, including IL-4, IL-5, IL-9, IL-10, and inflammasignals that have been shown to correlate with mucus gene activation have yet to be elucidated. tory cells including eosinophils and mast cells, activate mucus and muc5ac expression through increased secretion of The pathways from IL-4R␣ engagement to mucin gene expression have not been characterized. Yet studies have IL-13. These effects are dependent on IL-4R␣ expression on structural cells within the lung, presumably the airway begun to map some of the signaling pathways that activate mucin genes. Pseudomonas/LPS activates MUC2 gene tranepithelium itself, which has been shown to express both IL-4R␣ and IL-13R␣1 (52). Blocking mucus production and scription through a signaling pathway that is dependent on activation of NF-B and binding to the promoter of the reducing airway obstruction in asthma and chronic bronchitis, both of which have been shown to have elevated levels MUC2 gene (22) . The transcription factor NF-B controls the expression of multiple genes involved in immune reof IL-13 (53; J. Elias, personal communication), is now a realistic goal. These studies show that total inhibition of sponses that affect lung inflammation, including proinflammatory cytokines, adhesion molecules, chemokines, and IL-13 may be required for a significant effect, given the potency of this cytokine in mucus induction. 
